Seminars in Perinatology
Volume 31, Issue 4 , Pages 208-212 , August 2007

Adverse Pregnancy Outcome, the Uteroplacental Interface, and Preventive Strategies

  • Nazli Hossain, MBBS, FCPS
    • ,
  • Michael J. Paidas, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Michael J. Paidas, MD, Yale Women & Children’s Center for Blood Disorders, Yale University School of Medicine, 333 Cedar Street, FMB 339, New Haven, CT 06520.

References 

  1. Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia (Young Investigator Award). Am J Obstet Gynecol. 2004;190:1541–1547discussion 1547-1550
  2. Maynard SE, Venkatesha S, Thadhani R, et al. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005;57:1R–7R
  3. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992–1005
  4. Yu CK, Smith GC, Papageorghiou AT, et al. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol. 2005;193:429–436
  5. Kupferminc MJ. Thrombophilia and preeclampsia: the evidence so far. Clin Obstet Gynecol. 2005;48:406–415
  6. Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension. 2005;46:1270–1274
  7. Infante-Rivard C, Rivard GE, Guiguet M, et al. Thrombophilic polymorphisms and intrauterine growth restriction. Epidemiology. 2005;16:281–287
  8. Paidas MJ, Ku DH, Langhoff-Roos J, et al. Inherited thrombophilias and adverse pregnancy outcome: screening and management. Semin Perinatol. 2005;29:150–163
  9. Roque H, Paidas MJ, Funai EF, et al. Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost. 2004;91:290–295
  10. Salafia CM, Minior VK, Pezzullo JC, et al. Intrauterine growth restriction in infants of less than thirty-two weeks’ gestation: associated placental pathologic features. Am J Obstet Gynecol. 1995;173:1049–1057
  11. Ghidini A, Salafia CM, Pezzullo JC. Placental vascular lesions and likelihood of diagnosis of preeclampsia. Obstet Gynecol. 1997;90:542–545
  12. Gris JC, Quere I, Monpeyroux F, et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent: the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost. 1999;81:891–899
  13. Papageorghiou AT, Yu CK, Nicolaides KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2004;18:383–396
  14. Nicolaides KH, Bindra R, Turan OM, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006;27:13–17
  15. Spencer K, Yu CK, Cowans NJ, et al. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005;25:949–953
  16. Malone FD, Canick JA, Ball RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005;353:2001–2011
  17. Halligan A, Bonnar J, Sheppard B, et al. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynecol. 1994;101:488–492
  18. Paidas M, Ku DH, Triche E, et al. Does heparin therapy improve pregnancy outcome in patients with thrombophilias?. J Thromb Haemost. 2004;2:1194–1195
  19. Brenner B, Bar J, Ellis M, et al. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertil Steril. 2005;84:770–773
  20. Gris JC, Dekker G, Cohen H. Antithrombotic prophylaxis for pregnancy loss Prothrombotic mechanisms in preeclampsia (Inherited thrombophilia and pregnancy loss-epidemiology). Thromb Res. 2005;115(suppl 1):30–32
  21. Rodger M, Gris J-C, Quere I, et al. Important publication missing key information. Blood. 2004;104:3413–3414
  22. Polyzos NP, Mauri D, Tsappi M, et al. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv. 2007;62:202–206
  23. Hofmeyr GJ, Atallah AN, Duley L, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 3. 2006;CD001059
  24. Hutton B, Sharma R, Fergusson D, et al. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. Br J Obstet Gynaecol. 2007;114:134–142
  25. Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum. 2003;48:728–731
  26. Maki M, Kobayashi T, Terao T, et al. Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group. Thromb Haemost. 2000;84:583–590
  27. Sergio F, Maria Clara D, Gabriella F, et al. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy. 2006;25:115–127
  28. Duhl AJ, Paidas M, Ural SH, et al: Antithrombotic therapy and pregnancy. Consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse perinatal outcomes. Am J Obstet Gynecol 2007, in press
  29. Hills FA, Abrahams VM, Gonzalez-Timon B, et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod. 2006;12:237–243
  30. Urban G, Vergani P, Tironi R, et al: Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in antecedent pregnancy. International Journal of Fertility & Women’s Medicine, accepted for publication

PII: S0146-0005(07)00061-4

doi: 10.1053/j.semperi.2007.05.002

Seminars in Perinatology
Volume 31, Issue 4 , Pages 208-212 , August 2007

Article Tools